{"id":66463,"date":"2026-01-17T08:52:02","date_gmt":"2026-01-17T07:52:02","guid":{"rendered":"https:\/\/www.parkinson-hotline.com\/parkinson\/blog\/was-bedeutet-neuroplastizitaet-bei-parkinson-wirklich-copy\/"},"modified":"2026-02-03T04:18:33","modified_gmt":"2026-02-03T03:18:33","slug":"was-bedeutet-neuroplastizitaet-bei-parkinson-wirklich-copy","status":"publish","type":"post","link":"https:\/\/www.parkinson-hotline.com\/cs\/was-bedeutet-neuroplastizitaet-bei-parkinson-wirklich-copy\/","title":{"rendered":"Can the progression of Parkinson’s disease be slowed down?"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Lze zpomalit progresi Parkinsonovy choroby?<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

\u00a0<\/p>


\u00davod<\/strong>

Jednou z nej\u010dast\u011bj\u0161\u00edch ot\u00e1zek lid\u00ed s Parkinsonovou chorobou a jejich p\u0159\u00edbuzn\u00fdch je:
\u201cLze zpomalit postup nemoci?\u201d<\/strong><\/p>

Parkinsonova choroba je v sou\u010dasn\u00e9 dob\u011b nevyl\u00e9\u010diteln\u00e1. L\u00e9ka\u0159sk\u00e9 poznatky v\u0161ak ukazuj\u00ed, \u017ee n\u011bkter\u00e9 terapeutick\u00e9 postupy mohou m\u00edt pozitivn\u00ed vliv na funk\u010dn\u00ed pr\u016fb\u011bh onemocn\u011bn\u00ed.<\/p>

C\u00edlen\u00e9 cvi\u010den\u00ed, motorick\u00e9 u\u010den\u00ed a individu\u00e1ln\u00ed tr\u00e9nink na m\u00edru<\/strong> hraj\u00ed hlavn\u00ed roli - stejn\u011b jako ve specializovan\u00fdch form\u00e1ch terapie, jako je terapie GIGER\u00ae MD\u00ae.<\/p>

\u00a0<\/p>

\u00a0<\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Co vlastn\u011b znamen\u00e1 \u201czpomalen\u00ed postupu\u201d?<\/strong><\/p>

Kdy\u017e mluv\u00edme o progresi Parkinsonovy nemoci, nemluv\u00edme o zastaven\u00ed samotn\u00e9 nemoci, ale sp\u00ed\u0161e o:<\/p>

  • zachov\u00e1n\u00ed mobility po co nejdel\u0161\u00ed dobu,<\/li>
  • zpo\u017ed\u011bn\u00ed funk\u010dn\u00edch omezen\u00ed,<\/li>
  • zv\u00fd\u0161en\u00ed bezpe\u010dnosti a nez\u00e1vislosti v ka\u017edodenn\u00edm \u017eivot\u011b.

    <\/li><\/ul>

    Pr\u016fb\u011bh se u jednotliv\u00fdch osob zna\u010dn\u011b li\u0161\u00ed. Rozhoduj\u00edc\u00ed je, jak brzy a jak konkr\u00e9tn\u011b jsou prov\u00e1d\u011bna podp\u016frn\u00e1 opat\u0159en\u00ed.<\/p>


    Jak\u00e9 faktory ovliv\u0148uj\u00ed progresi Parkinsonovy choroby?<\/strong><\/p>

    Na progresi Parkinsonovy choroby maj\u00ed mimo jin\u00e9 vliv:<\/p>

    • za\u010d\u00e1tek a typ onemocn\u011bn\u00ed,<\/li>
    • genetick\u00e9 a biologick\u00e9 faktory,<\/li>
    • farmakologick\u00e1 l\u00e9\u010dba,<\/li>
    • \u00farove\u0148 aktivity a pohybov\u00e9 chov\u00e1n\u00ed.

      <\/li><\/ul>

      Biologick\u00e9 faktory sice ovlivnit nelze, ale v\u00fdznamn\u011b k tomu m\u016f\u017ee p\u0159isp\u011bt zejm\u00e9na c\u00edlen\u00e1 pohybov\u00e1 terapie.<\/p>

      \u00a0
      Jakou roli hraje cvi\u010den\u00ed?<\/strong><\/p>

      Cvi\u010den\u00ed je dnes pova\u017eov\u00e1no za kl\u00ed\u010dovou sou\u010d\u00e1st l\u00e9\u010dby Parkinsonovy choroby. Studie ukazuj\u00ed, \u017ee pravideln\u00e9, strukturovan\u00e9 cvi\u010den\u00ed:<\/p>

      • si m\u016f\u017ee d\u00e9le udr\u017eet pohyblivost,<\/li>
      • stabilizuje ka\u017edodenn\u00ed funkce,<\/li>
      • m\u016f\u017ee sn\u00ed\u017eit riziko p\u00e1du.<\/li><\/ul>

        Ne v\u0161echna cvi\u010den\u00ed jsou v\u0161ak stejn\u011b \u00fa\u010dinn\u00e1. Rozhoduj\u00edc\u00ed je, zda je cvi\u010den\u00ed c\u00edlen\u00e9, v\u011bdom\u00e9 a zam\u011b\u0159en\u00e9 na u\u010den\u00ed.<\/p>

        \u00a0
        Pro\u010d je c\u00edlen\u00fd tr\u00e9nink d\u016fle\u017eit\u011bj\u0161\u00ed ne\u017e \u010dist\u00e1 aktivita<\/strong><\/p>

        Proch\u00e1zky nebo celkov\u00e1 aktivita jsou u\u017eite\u010dn\u00e9, ale \u010dasto nesta\u010d\u00ed k dosa\u017een\u00ed trval\u00e9ho zlep\u0161en\u00ed funk\u010dnosti.
        Modern\u00ed terapeutick\u00e9 p\u0159\u00edstupy - jako je nap\u0159\u00edklad terapie GIGER\u00ae MD\u00ae - se proto zam\u011b\u0159uj\u00ed na:<\/p>

        • aktivn\u00ed, v\u011bdom\u011b \u0159\u00edzen\u00e9 pohybov\u00e9 sekvence,<\/li>
        • komplexn\u00ed po\u017eadavky na koordinaci a rovnov\u00e1hu,<\/li>
        • rytmick\u00e9 a strukturovan\u00e9 pohybov\u00e9 vzorce,<\/li>
        • individu\u00e1ln\u011b p\u0159izp\u016fsoben\u00e9 tr\u00e9ninkov\u00e9 podn\u011bty.

          <\/li><\/ul>

          C\u00edlem je c\u00edlen\u011b zat\u011b\u017eovat nervov\u00fd syst\u00e9m a stabilizovat funk\u010dn\u00ed schopnosti na co nejdel\u0161\u00ed dobu.
          \u00a0<\/p>

          Souvislost s neuroplasticitou<\/strong><\/p>

          I p\u0159i Parkinsonov\u011b chorob\u011b je mozek schopen se u\u010dit. Tato schopnost p\u0159izp\u016fsoben\u00ed se naz\u00fdv\u00e1 neuroplasticita.
          Terapie, jako je terapie GIGER\u00ae MD\u00ae, vyu\u017e\u00edvaj\u00ed tento princip t\u00edm, \u017ee:<\/p>

          • \u0159e\u0161\u00ed n\u011bkolik smyslov\u00fdch a pohybov\u00fdch syst\u00e9m\u016f sou\u010dasn\u011b,<\/li>
          • kombinace koordina\u010dn\u00edch a rytmick\u00fdch pohyb\u016f,<\/li>
          • aktivn\u00ed podpora motorick\u00e9ho u\u010den\u00ed.<\/li><\/ul>

            Neuroplasticita neznamen\u00e1 vyl\u00e9\u010den\u00ed, ale sp\u00ed\u0161e lep\u0161\u00ed vyu\u017eit\u00ed st\u00e1vaj\u00edc\u00edch nervov\u00fdch zdroj\u016f.<\/p>

            \u00a0
            Jak\u00e1 jsou omezen\u00ed?<\/strong><\/p>


            Jakkoli je c\u00edlen\u00e1 pohybov\u00e1 terapie d\u016fle\u017eit\u00e1, nenahrazuje l\u00e9ka\u0159skou l\u00e9\u010dbu. Parkinsonova choroba z\u016fst\u00e1v\u00e1 progresivn\u00edm neurologick\u00fdm onemocn\u011bn\u00edm. C\u00edlem proto nen\u00ed vyl\u00e9\u010dit nemoc, ale sp\u00ed\u0161e:<\/p>

            • zpomalit funk\u010dn\u00ed \u00fapadek,<\/li>
            • udr\u017eet kvalitu \u017eivota co nejd\u00e9le,<\/li>
            • podporovat bezpe\u010dnost a nez\u00e1vislost v ka\u017edodenn\u00edm \u017eivot\u011b.<\/li><\/ul>

              Terapeutick\u00e9 p\u0159\u00edstupy, jako je terapie GIGER\u00ae MD\u00ae, by m\u011bly b\u00fdt ch\u00e1p\u00e1ny jako dopl\u0148kov\u00e1, podp\u016frn\u00e1 opat\u0159en\u00ed.<\/p>

              \u00a0
              Z\u00e1v\u011br<\/strong><\/p>

              Parkinsonova choroba je nevyl\u00e9\u010diteln\u00e1. Posti\u017een\u00ed v\u0161ak mohou aktivn\u011b p\u0159isp\u011bt k pozitivn\u00edmu ovlivn\u011bn\u00ed funk\u010dn\u00edho pr\u016fb\u011bhu nemoci.
              Pravideln\u00e9 a c\u00edlen\u00e9 cvi\u010den\u00ed - zejm\u00e9na v r\u00e1mci strukturovan\u00fdch forem terapie, jako je terapie GIGER\u00ae MD\u00ae - m\u016f\u017ee pomoci udr\u017eet pohyblivost, koordinaci a bezpe\u010dnost v ka\u017edodenn\u00edm \u017eivot\u011b po del\u0161\u00ed dobu.

              Autor: Combo AG, v\u00fdrobce a distributor terapie GIGER\u00ae MD\u00ae Medical<\/strong> \u2028
              pozn\u00e1mka: Tento \u010dl\u00e1nek m\u00e1 pouze informativn\u00ed charakter a nenahrazuje l\u00e9ka\u0159skou radu nebo l\u00e9\u010dbu.
              Posledn\u00ed aktualizace: 2026<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

              Can the progression of Parkinson’s disease be slowed down? \u00a0 Introduction One of the most common questions asked by people with Parkinson’s disease and their relatives is:\u201cCan the progression of the disease be slowed down?\u201d Parkinson’s disease is currently incurable. However, medical findings show that certain therapeutic approaches can have a positive effect on the […]<\/p>\n","protected":false},"author":1,"featured_media":66355,"comment_status":"closed","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[7354,7355],"tags":[],"class_list":["post-66463","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog-en","category-parkinson-en"],"_links":{"self":[{"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/posts\/66463","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/comments?post=66463"}],"version-history":[{"count":11,"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/posts\/66463\/revisions"}],"predecessor-version":[{"id":66673,"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/posts\/66463\/revisions\/66673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/media\/66355"}],"wp:attachment":[{"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/media?parent=66463"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/categories?post=66463"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.parkinson-hotline.com\/cs\/wp-json\/wp\/v2\/tags?post=66463"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}